Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gogadis A"'
Autor:
Anna Lea Amylidi, Aristeidis Gogadis, Melina Yerolatsite, George Zarkavelis, Nanteznta Torounidou, Varvara Keramisanou, Eleftherios Kampletsas, Davide Mauri
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10509-10518 (2023)
Immune checkpoint inhibitors, such as anti-PD-1 and anti-CTLA-4 inhibitors, have become the standard of care for many cancer types. However, they induce immune-related adverse events (irAEs), including neurotoxicity and hypophysitis. The incidence an
Externí odkaz:
https://doaj.org/article/0f91f00460cc465c94fd9ce28b23b0ff
Autor:
Amylidi, Anna Lea1,2 (AUTHOR) agogadis@gmail.com, Gogadis, Aristeidis1,2 (AUTHOR) m.yerolatsite@gmail.com, Yerolatsite, Melina1,2 (AUTHOR) gzarkavelis@outlook.com, Zarkavelis, George1,2 (AUTHOR) nadia.torou@gmail.com, Torounidou, Nanteznta1,2 (AUTHOR) barbiekermds@gmail.com, Keramisanou, Varvara1,2 (AUTHOR) lekable4@yahoo.gr, Kampletsas, Eleftherios1,2 (AUTHOR) dvd.mauri@gmail.com, Mauri, Davide1,2,3 (AUTHOR)
Publikováno v:
Current Oncology. Dec2023, Vol. 30 Issue 12, p10509-10518. 10p.
Autor:
Davide Mauri, Eleftherios Kampletsas, George Smyris, Lampriani Tsali, Periklis Tsekeris, Haralampos Harissis, Konstantinos Kamposioras, Maria Tolia, Thomas Hyphantis, Panagiotis Ntellas, Ioanna Gazouli, Georgios Zarkavelis, Leonidas Mavroeidis, Anna-Lea Amylidi, Nanteznta Torounidou, Aristeidis Gogadis, Joanna Nixon
Publikováno v:
Palliative Medicine Reports, Vol 2, Iss 1, Pp 365-368 (2021)
Background: Upon the onset of a debilitating rapidly evolving condition (such as cancer or a rapidly progressing myopathy, neuropathy, respiratory disease, or a severe traumatic injury), individuals have limited time to find a new home or make radica
Externí odkaz:
https://doaj.org/article/f8be624a9a43466e9ce74eb654f969e5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Forum of Clinical Oncology, Vol 10, Iss 2, Pp 2-14 (2020)
The emergence of cyclin-dependent kinase (CDK) 4 and 6 inhibitors has brought a new approach in the treatment of advanced hormone receptor (HR) positive breast cancer and human epidermal growth factor (HER) 2 negative breast cancer. To date, three CD
Externí odkaz:
https://doaj.org/article/b161495de00941ab858ace9cc4e22453
Autor:
Vasiliki, Tzelepi C.1 (AUTHOR) vtzelepi@hotmail.com, Aristeidis, Gogadis T.1 (AUTHOR), Christos, Adamidis K.2 (AUTHOR), Timotheadou, Eleni T.2 (AUTHOR)
Publikováno v:
Forum of Clinical Oncology. Dec2019, Vol. 10 Issue 2, p2-14. 13p.
Autor:
Panagiotis, Filis, Afroditi, Kanellopoulou, Aristeidis, Gogadis, Nikolaos, Filis, Konstantinos, Kamposioras, Fani, Kapoulitsa, Davide, Mauri
Publikováno v:
Annals of gastroenterology. 36(1)
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) promised to transform the management of peritoneal carcinomatosis (PC). Forty years since the introduction of the technique, published data from randomized co
Autor:
Filis, Panagiotis, Kanellopoulou, Afroditi, Gogadis, Aristeidis, Filis, Nikolaos, Kamposioras, Konstantinos, Kapoulitsa, Fani, Mauri, Davide
Publikováno v:
Annals of Gastroenterology; 2023, Vol. 36 Issue 1, p87-96, 11p
Publikováno v:
Annals of Oncology. 33:S727
Autor:
Filis, P., Kanellopoulou, A., Gogadis, A., Filis, N., Kamposioras, K.V., Kapoulitsa, F., Mauri, D.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S727-S727